MAZE (MAZE) reported D&A of $444K in Q1 2026.

How has MAZE's D&A changed year-over-year?

MAZE's D&A decreased by 35.1% year-over-year, from $684K to $444K.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

MAZE MAZE D&A

D&A at other companies

Vertex PharmaceuticalsVRTX

$55.9M+15.5%

Septerna, Inc.SEPN

$421K+6.0%

Stoke Therapeutics, Inc.STOK

$439K-8.0%

Olema Pharmaceuticals, Inc.OLMA

$119K-7.0%

ZymeworksZYME

$963K-1.8%

Nurix Therapeutics, Inc.NRIX

$2.2M-6.6%

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$26.6M+25.0%

Net income-$24.2M+26.2%

EPS (diluted)-$0.45+60.9%

Balance sheet

See full

Cash & equivalents$198.8M-32.5%

Total debt$61.2M+137%

Total equity$341.7M+17.0%

Total assets$419.7M+26.1%

Cash flow

See full

Operating cash flow-$39.1M-32.5%

CapEx$93.0K-68.9%

Free cash flow-$39.2M-31.5%

Valuation

See full

Market cap$1.48B+201%

Enterprise value$1.34B—

P/S7.9×—

Profitability

See full

Operating margin-71.5%—

Net margin-65.4%—

FCF margin-65.1%—

Returns & leverage

See full

Return on equity-38.7%—

Debt / equity0.2×+0.1×

Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MAZE's D&A?: MAZE (MAZE) reported D&A of $444K in Q1 2026.
How has MAZE's D&A changed year-over-year?: MAZE's D&A decreased by 35.1% year-over-year, from $684K to $444K.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.